Drugs.com - Pharma Industry News

FDA Approves Tablet Form of Evrysdi for Spinal Muscular Atrophy

TUESDAY, Feb. 18, 2025 -- The U.S. Food and Drug Administration has approved a new drug application for a tablet version of Evrysdi (risdiplam) for people living with spinal muscular atrophy (SMA).The new tablet is expected to be available in the...

Feb 18, 2025 - 18:49
 0
FDA Approves Tablet Form of Evrysdi for Spinal Muscular Atrophy
TUESDAY, Feb. 18, 2025 -- The U.S. Food and Drug Administration has approved a new drug application for a tablet version of Evrysdi (risdiplam) for people living with spinal muscular atrophy (SMA).The new tablet is expected to be available in the...
Read More

Tags:

Previous Article

2019 to 2020 Saw 17.9 Percent Decrease in Ophthalmic Procedures in Seniors

Next Article

ASA: Intra-Arterial Tenecteplase Beneficial for Large Vessel Occlusion

Related Posts

Infection-Related Hospitalization Linked to Heart Failure

Infection-Related Hospitalization Linked to Heart Failure

Feb 15, 2025  0

In 2023, 1.4 Percent of U.S. Children Ever Experienced Post-COVID Condition

In 2023, 1.4 Percent of U.S. Children Ever Experienced ...

Feb 12, 2025  0

At 10 Years, Roux-en-Y Gastric Bypass Superior for Patient Excess BMI Loss

At 10 Years, Roux-en-Y Gastric Bypass Superior for Pati...

Feb 24, 2025  0